flumazenil has been researched along with Chronic Pain in 1 studies
Flumazenil: A potent benzodiazepine receptor antagonist. Since it reverses the sedative and other actions of benzodiazepines, it has been suggested as an antidote to benzodiazepine overdoses.
flumazenil : An organic heterotricyclic compound that is 5,6-dihydro-4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted at positions 3, 5, 6, and 8 by ethoxycarbonyl, methyl, oxo, and fluoro groups, respectively. It is used as an antidote to benzodiazepine overdose.
Chronic Pain: Aching sensation that persists for more than a few months. It may or may not be associated with trauma or disease, and may persist after the initial injury has healed. Its localization, character, and timing are more vague than with acute pain.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Regional gray matter alterations in chronic pain, as detected with voxel-based morphometry of anatomical magnetic resonance images, are commonly interpreted to reflect neurodegeneration, but this assumption has not been tested." | 1.46 | Histological Underpinnings of Grey Matter Changes in Fibromyalgia Investigated Using Multimodal Brain Imaging. ( Araujo, D; Ceko, M; Daigle-Martel, A; Feier, NA; Fitzcharles, MA; Funck, T; Narayanan, S; Pomares, FB; Roy, S; Schweinhardt, P; Stikov, N; Thiel, A, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pomares, FB | 1 |
| Funck, T | 1 |
| Feier, NA | 1 |
| Roy, S | 1 |
| Daigle-Martel, A | 1 |
| Ceko, M | 1 |
| Narayanan, S | 1 |
| Araujo, D | 1 |
| Thiel, A | 1 |
| Stikov, N | 1 |
| Fitzcharles, MA | 1 |
| Schweinhardt, P | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Investigation of the Effect of Initial Central Sensitization Severity on Treatment Response in Patients With Fibromyalgia[NCT05020600] | 40 participants (Anticipated) | Observational | 2021-08-19 | Recruiting | |||
| Investigation of the Relationship Between Neuropathic Complaints and Central Sensitization in Patients With Fibromyalgia[NCT05701696] | 111 participants (Anticipated) | Observational | 2023-01-16 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 other study available for flumazenil and Chronic Pain
| Article | Year |
|---|---|
Histological Underpinnings of Grey Matter Changes in Fibromyalgia Investigated Using Multimodal Brain Imaging.
Topics: Aged; Body Water; Brain Chemistry; Chronic Pain; Female; Fibromyalgia; Flumazenil; Gray Matter; Huma | 2017 |
Histological Underpinnings of Grey Matter Changes in Fibromyalgia Investigated Using Multimodal Brain Imaging.
Topics: Aged; Body Water; Brain Chemistry; Chronic Pain; Female; Fibromyalgia; Flumazenil; Gray Matter; Huma | 2017 |
Histological Underpinnings of Grey Matter Changes in Fibromyalgia Investigated Using Multimodal Brain Imaging.
Topics: Aged; Body Water; Brain Chemistry; Chronic Pain; Female; Fibromyalgia; Flumazenil; Gray Matter; Huma | 2017 |
Histological Underpinnings of Grey Matter Changes in Fibromyalgia Investigated Using Multimodal Brain Imaging.
Topics: Aged; Body Water; Brain Chemistry; Chronic Pain; Female; Fibromyalgia; Flumazenil; Gray Matter; Huma | 2017 |